These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35603888)

  • 21. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
    J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Biologics on the Need for Procedural Interventions, Systemic Medications, and Healthcare Utilization in Patients with Hidradenitis Suppurativa: Real-World Data from the UNITE Registry.
    Oliveira M; Rahawi K; Duan Y; Lane M; Amin AZ; Sayed CJ
    Dermatol Ther (Heidelb); 2023 Jul; 13(7):1577-1585. PubMed ID: 37314696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients.
    Yazdanyar S; Boer J; Ingvarsson G; Szepietowski JC; Jemec GB
    Dermatology; 2011; 222(4):342-6. PubMed ID: 21757878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
    Molinelli E; Brisigotti V; Simonetti O; Sapigni C; D'Agostino GM; Rizzetto G; Giacchetti A; Offidani A
    Dermatol Ther; 2022 Jun; 35(6):e15439. PubMed ID: 35278025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
    Barmatz S; Fisch-Gilad S; Hackett A; Barak Levitt J; Dalal A; Taieb Y; Kremer N; Levi A; Pavlovsky L; Hodak E; Yahav D; Sherman S
    Dermatology; 2022; 238(4):772-784. PubMed ID: 35086093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients.
    McPhie ML; Bridgman AC; Kirchhof MG
    J Cutan Med Surg; 2019; 23(3):270-276. PubMed ID: 30658534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of treatments for hidradenitis suppurativa.
    Rambhatla PV; Lim HW; Hamzavi I
    Arch Dermatol; 2012 Apr; 148(4):439-46. PubMed ID: 22184715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic use in hidradenitis suppurativa: patient perspectives and barriers.
    De DR; Shih T; Fixsen D; Brooks B; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Nov; 33(7):3060-3062. PubMed ID: 35737883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.
    Sachdeva M; Kim P; Mufti A; Maliyar K; Sibbald C; Alavi A
    J Cutan Med Surg; 2022; 26(2):176-180. PubMed ID: 34587768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients.
    Bettoli V; Manfredini M; Massoli L; Carillo C; Barozzi A; Amendolagine G; Ruina G; Musmeci D; Libanore M; Curtolo A; Mantovani L; Contini C; Pellacani G; Corazza M
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):930-936. PubMed ID: 30394587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
    Midgette B; Strunk A; Akilov O; Alavi A; Ardon C; Bechara FG; Cohen AD; Cohen S; Daveluy S; Del Marmol V; Delage M; Esmann S; Fisher S; Giamarellos-Bourboulis EJ; Glowaczewska A; Goldfarb N; Brant EG; Grimstad Ø; Guilbault S; Hamzavi I; Hughes R; Ingram JR; Jemec GBE; Ju Q; Kappe N; Kirby B; Kirby JS; Lowes MA; Matusiak L; Micha S; Micheletti R; Miller AP; Moseng D; Naik H; Nassif A; Nikolakis G; Paek SY; Pascual JC; Prens E; Resnik B; Riad H; Sayed C; Smith SD; Soliman Y; Szepietowski JC; Tan J; Thorlacius L; Tzellos T; van der Zee HH; Villumsen B; Wang L; Zouboulis C; Garg A
    Br J Dermatol; 2022 Dec; 187(6):927-935. PubMed ID: 36056741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience.
    Donnarumma M; Marasca C; Palma M; Vastarella M; Annunziata MC; Fabbrocini G
    G Ital Dermatol Venereol; 2020 Dec; 155(6):749-753. PubMed ID: 30249083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic Treatment of Hidradenitis Suppurativa.
    Bettoli V; Join-Lambert O; Nassif A
    Dermatol Clin; 2016 Jan; 34(1):81-9. PubMed ID: 26617361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
    Porter ML; Golbari NM; Lockwood SJ; Kimball AB
    Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acitretin.
    Tan MG; Shear NH; Walsh S; Alhusayen R
    J Cutan Med Surg; 2017; 21(1):48-53. PubMed ID: 27432818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures: experiences from a specialty clinic.
    Kearney N; Hughes R; Kirby B
    Clin Exp Dermatol; 2023 Jul; 48(7):790-792. PubMed ID: 37017188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa.
    Timofte I; Smith H
    Bull Hosp Jt Dis (2013); 2021 Jun; 79(2):137-140. PubMed ID: 34081891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
    Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
    Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.